Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elise Lim

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Statistics in Medicine|December 5, 2019
A unified method for rare variant analysis of gene-environment interactionsElise Lim, Han Chen, Josée Dupuis, et al.
Research and Practice in Thrombosis and Haemostasis|May 24, 2024
Emicizumab is efficacious in people with hemophilia A with comorbidities aged ≥50 years: analysis of 4 phase III trialsVíctor Jiménez-Yuste, Johannes Oldenburg, Eunice Tzeng, et al.
Journal of the American Heart Association|February 15, 2021
Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring StudyHiroaki Ikezaki, Elise Lim, L Adrienne Cupples, et al.
Genetic Epidemiology|June 24, 2021
Exome sequence association study of levels and longitudinal change of cardiovascular risk factor phenotypes in European Americans and African Americans from the Atherosclerosis Risk in Communities StudyElena V Feofanova, Elise Lim, Han Chen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 18, 2024
Pain-Related Quality of Life Outcomes in People With Haemophilia A Receiving Emicizumab: A Post Hoc Analysis of the HAVEN 1, 3 and 4 and STASEY StudiesCedric Hermans, Mark W Skinner, Brittany Gentile, et al.
Nutrients|April 26, 2025
Lipoprotein(a) and Risk of Incident Atherosclerotic Cardiovascular Disease: Impact of High-Sensitivity C-Reactive Protein and Risk Variability Among Human Clinical SubgroupsRon C Hoogeveen, Margaret R Diffenderfer, Elise Lim, et al.
Genetic Epidemiology|September 1, 2020
Efficient gene-environment interaction tests for large biobank-scale sequencing studiesXinyu Wang, Elise Lim, Ching-Ti Liu, et al.
Atherosclerosis|February 1, 2023
Atherosclerotic cardiovascular disease risk and small dense low-density lipoprotein cholesterol in men, women, African Americans and non-African Americans: The pooling projectErnst J Schaefer, Hiroaki Ikezaki, Margaret R Diffenderfer, et al.
Clinical Chemistry|June 27, 2019
Direct Versus Calculated LDL Cholesterol and C-Reactive Protein in Cardiovascular Disease Risk Assessment in the Framingham Offspring StudyHiroaki Ikezaki, Virginia A Fisher, Elise Lim, et al.
BMC Proceedings|October 3, 2018
Network analysis of drug effect on triglyceride-associated DNA methylationElise Lim, Hanfei Xu, Peitao Wu, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Statistics in Medicine|December 5, 2019
A unified method for rare variant analysis of gene-environment interactionsElise Lim, Han Chen, Josée Dupuis, et al.
Research and Practice in Thrombosis and Haemostasis|May 24, 2024
Emicizumab is efficacious in people with hemophilia A with comorbidities aged ≥50 years: analysis of 4 phase III trialsVíctor Jiménez-Yuste, Johannes Oldenburg, Eunice Tzeng, et al.
Journal of the American Heart Association|February 15, 2021
Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring StudyHiroaki Ikezaki, Elise Lim, L Adrienne Cupples, et al.
Genetic Epidemiology|June 24, 2021
Exome sequence association study of levels and longitudinal change of cardiovascular risk factor phenotypes in European Americans and African Americans from the Atherosclerosis Risk in Communities StudyElena V Feofanova, Elise Lim, Han Chen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 18, 2024
Pain-Related Quality of Life Outcomes in People With Haemophilia A Receiving Emicizumab: A Post Hoc Analysis of the HAVEN 1, 3 and 4 and STASEY StudiesCedric Hermans, Mark W Skinner, Brittany Gentile, et al.
Nutrients|April 26, 2025
Lipoprotein(a) and Risk of Incident Atherosclerotic Cardiovascular Disease: Impact of High-Sensitivity C-Reactive Protein and Risk Variability Among Human Clinical SubgroupsRon C Hoogeveen, Margaret R Diffenderfer, Elise Lim, et al.
Genetic Epidemiology|September 1, 2020
Efficient gene-environment interaction tests for large biobank-scale sequencing studiesXinyu Wang, Elise Lim, Ching-Ti Liu, et al.
Atherosclerosis|February 1, 2023
Atherosclerotic cardiovascular disease risk and small dense low-density lipoprotein cholesterol in men, women, African Americans and non-African Americans: The pooling projectErnst J Schaefer, Hiroaki Ikezaki, Margaret R Diffenderfer, et al.
Clinical Chemistry|June 27, 2019
Direct Versus Calculated LDL Cholesterol and C-Reactive Protein in Cardiovascular Disease Risk Assessment in the Framingham Offspring StudyHiroaki Ikezaki, Virginia A Fisher, Elise Lim, et al.
BMC Proceedings|October 3, 2018
Network analysis of drug effect on triglyceride-associated DNA methylationElise Lim, Hanfei Xu, Peitao Wu, et al.
Pageof 3